# Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing

> **NCT07243249** · NA · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2000 (estimated)

## Conditions studied

- Respiratory Infections
- Antibiotic

## Interventions

- **DIAGNOSTIC_TEST:** TROD

## Key facts

- **NCT ID:** NCT07243249
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-07
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243249, "Study Evaluating the Impact of Using Triplex Rapid Diagnostic Tests (SARS-CoV-2/Influenza/RSV) on Antibiotic Prescribing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07243249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*